<i>Pediococcus acidilactici</i> pA1c<sup>®</sup> Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota

<i>Pediococcus acidilactici</i> pA1c<sup>®</sup> Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota

Type 2 diabetes (T2D) is a complex metabolic disease, which involves maintained hyperglycemia, mainly due to the development of an insulin resistance process. Metformin administration is the most prescribed treatment for diabetic patients. In a previously published study, we demonstrated that <i&...

Full description

Bibliographic Details
Main Authors: Miriam Cabello-Olmo, María Oneca, Raquel Urtasun, María J. Pajares, Saioa Goñi, José I. Riezu-Boj, Fermín I. Milagro, Josune Ayo, Ignacio J. Encio, Miguel Barajas, Miriam Araña
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceutics
Subjects:
<i>Pediococcus acidilactici</i>
probiotic
metformin
high-fat diet
diabetes
glycaemia
Online Access:https://www.mdpi.com/1999-4923/15/4/1203

Internet

https://www.mdpi.com/1999-4923/15/4/1203

Similar Items